Finally, we demonstrate the cytotoxicity of this compound against different cancer cell lines that are dependent on HH signaling for their survival, adding benzo[cd]indol‐2(1H)‐ones to the growing set of BET bromodomain inhibitors that are effective downstream HH pathway inhibitors. The gene discussed is DNER; the disease is cancer.